Kohei Shitara Selected Research

Kohei Shitara Research Topics

Disease

121	Stomach Neoplasms (Stomach Cancer) 08/2022 - 10/2005
108	Neoplasms (Cancer) 09/2022 - 01/2008
44	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 12/2005
31	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2006
27	Adenocarcinoma 08/2022 - 09/2011
14	Neutropenia 01/2021 - 02/2011
12	Disease Progression 01/2022 - 05/2011
7	Esophageal Neoplasms (Esophageal Cancer) 11/2012 - 08/2006
6	Interstitial Lung Diseases (Interstitial Lung Disease) 05/2022 - 01/2006
6	Microsatellite Instability 02/2022 - 01/2021
6	Ascites 01/2022 - 11/2009
6	Breast Neoplasms (Breast Cancer) 01/2021 - 07/2006
6	Anemia 01/2021 - 06/2007
5	Pneumonia (Pneumonitis) 05/2022 - 01/2006
4	Diarrhea 07/2022 - 05/2011
4	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2022 - 12/2005
4	Febrile Neutropenia 01/2022 - 01/2017
4	Fatigue 12/2021 - 07/2011
4	Fever (Fevers) 12/2021 - 01/2006
4	Colonic Neoplasms (Colon Cancer) 07/2011 - 07/2007
3	Rectal Neoplasms (Rectal Cancer) 04/2021 - 07/2008
3	Thrombocytopenia (Thrombopenia) 01/2021 - 08/2011
3	Leukopenia 01/2020 - 08/2011
3	Anorexia 01/2020 - 07/2011
3	Hemorrhage 01/2018 - 08/2015
3	Jaundice (Icterus) 08/2011 - 07/2009
3	Dyspnea (Shortness of Breath) 03/2011 - 01/2006
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2008 - 11/2005
2	Sudden Death 01/2022 - 01/2019
2	Liver Failure 01/2022 - 06/2008
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 09/2017
2	Exanthema (Rash) 01/2021 - 01/2020
2	Vomiting 01/2020 - 01/2019
2	Nausea 01/2020 - 11/2016

Drug/Important Bio-Agent (IBA)

23	pembrolizumabIBA 08/2022 - 01/2018
20	Paclitaxel (Taxol)FDA LinkGeneric 07/2022 - 01/2006
20	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 10/2005
19	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2022 - 12/2005
18	Immune Checkpoint InhibitorsIBA 09/2022 - 09/2017
18	Trastuzumab (Herceptin)FDA Link 02/2022 - 07/2006
17	Cisplatin (Platino)FDA LinkGeneric 08/2022 - 08/2006
17	Biomarkers (Surrogate Marker)IBA 08/2022 - 06/2012
15	Fluorouracil (Carac)FDA LinkGeneric 11/2021 - 12/2005
14	trifluridine tipiracil drug combinationIBA 01/2022 - 01/2016
14	Bevacizumab (Avastin)FDA Link 01/2021 - 07/2008
13	Monoclonal AntibodiesIBA 02/2022 - 10/2016
13	NivolumabIBA 02/2022 - 01/2019
13	Cetuximab (Erbitux)FDA Link 01/2020 - 04/2009
12	human ERBB2 proteinIBA 08/2022 - 05/2011
12	RamucirumabIBA 01/2021 - 02/2015
9	trastuzumab deruxtecanIBA 05/2022 - 01/2019
9	Docetaxel (Taxotere)FDA Link 12/2021 - 11/2006
8	Pharmaceutical PreparationsIBA 05/2022 - 06/2006
8	Capecitabine (Xeloda)FDA Link 01/2022 - 12/2005
8	Leucovorin (Folinic Acid)FDA Link 11/2021 - 07/2007
6	regorafenibIBA 01/2022 - 12/2016
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 02/2015
6	PlatinumIBA 09/2020 - 07/2007
6	S-1 plus cisplatinIBA 01/2016 - 11/2010
5	B7-H1 AntigenIBA 08/2022 - 10/2018
5	ErbB Receptors (EGF Receptor)IBA 01/2022 - 04/2015
5	LigandsIBA 01/2021 - 05/2017
4	napabucasinIBA 07/2022 - 05/2019
4	Immunoconjugates (Immunoconjugate)IBA 05/2022 - 11/2017
4	AntibodiesIBA 02/2022 - 05/2017
4	Cytotoxins (Cytolysins)IBA 10/2021 - 06/2011
4	Panitumumab (Vectibix)FDA Link 10/2020 - 04/2009
4	taxaneIBA 02/2020 - 06/2006
4	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2020 - 02/2015
3	lenvatinibIBA 01/2022 - 01/2020
3	Circulating Tumor DNAIBA 10/2021 - 12/2016
3	Taxoids (Taxanes)IBA 03/2021 - 06/2011
3	Epidermal Growth Factor (EGF)IBA 01/2021 - 07/2012
3	Ado-Trastuzumab EmtansineIBA 02/2020 - 10/2016
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 06/2018
3	130-nm albumin-bound paclitaxelIBA 01/2019 - 01/2017
3	Gemcitabine FDA Link 01/2017 - 11/2005
3	thiamine triphosphorate (TTP)IBA 04/2014 - 07/2007
2	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2022 - 05/2022
2	TAS-116IBA 12/2021 - 01/2019
2	dUTP pyrophosphataseIBA 01/2021 - 01/2019
2	Immune Checkpoint ProteinsIBA 01/2021 - 01/2018
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2019
2	AntigensIBA 01/2021 - 10/2009
2	TAS-114IBA 01/2021 - 01/2019
2	Phosphotransferases (Kinase)IBA 01/2020 - 01/2019

Therapy/Procedure

102	Drug Therapy (Chemotherapy) 09/2022 - 12/2005
61	Therapeutics 01/2022 - 10/2005
19	Combination Drug Therapy (Combination Chemotherapy) 01/2020 - 07/2006
10	Adjuvant Chemotherapy 01/2022 - 11/2008
9	Immunotherapy 02/2022 - 01/2018
7	Gastrectomy 01/2022 - 10/2007
7	Precision Medicine 03/2021 - 09/2018
7	Radiotherapy 01/2020 - 06/2007
6	Chemoradiotherapy 11/2012 - 08/2006
4	Lymph Node Excision (Lymph Node Dissection) 01/2020 - 07/2006
3	Aftercare (After-Treatment) 01/2018 - 07/2007
2	Neoadjuvant Therapy 01/2022 - 10/2007
2	Adjuvant Chemoradiotherapy 04/2021 - 07/2006